BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Thermo Fisher Introduces PowerFlex Thermal Cycler To Simplify Complex PCR Workflows

A next-generation PCR system designed to help labs manage increasing workflow complexity with greater flexibility, speed and confidence in reproducible res...

April 17, 2026 | News

Mabwell Advances Alpha Synuclein PET Tracer Into Phase I Strengthening Early Diagnosis Of Neurodegenerative Disorders

Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that 18F-FD4 (R&D code: SST0...

April 16, 2026 | News

Samsung Bioepis Initiates Phase 1 Clinical Trial for Novel ADC Candidate SBE303 Targeting Nectin 4

Samsung Bioepis Co., Ltd. announced the initiation of a Phase 1 clinical trial for SBE303, its first novel antibody drug conjugate candidate designed...

April 16, 2026 | News

Hoth Therapeutics Reports Positive HT VA Study Data Highlighting GDNF Driven Metabolic Reprogramming In Fatty Liver Disease

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, announced positive data from its HT-VA study, conducted unde...

April 15, 2026 | News

Caliway Secures Third Aesthetic Surgery Journal Recognition For CBL 514 Phase 2b Fat Reduction Study

Clinical results from Caliway's CBL-0204 Phase 2b study of its fat reduction drug candidate CBL-514 for localized fat reduction have been accepted by the...

April 15, 2026 | News

Thermo Fisher Scientific Partners HealthVerity To Advance Data Driven Clinical Development

Thermo Fisher Scientific, the world leader in serving science, announced a strategic data collaboration with HealthVerity, a leading real-world data (RWD) ...

April 14, 2026 | News

DualityBio Secures NMPA Review For Trastuzumab Pamirtecan In HER2 Positive Breast Cancer

DualityBio announced that the Biologics License Application (BLA) for the investigational antibody-drug conjugate ("ADC") trastuzumab pamirtecan ("T-Pam", ...

April 14, 2026 | News

AnBogen Therapeutics Showcases Imofinostat Breakthroughs At AACR Annual Meeting 2026

AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, announced that two key research abstracts regarding its lead co...

April 14, 2026 | Report

Shanghai Ark Biopharmaceutical Advances First In Human Trial Of Long Acting Influenza Therapy AK0406

Shanghai Ark Biopharmaceutical Co., Ltd. announced that the first cohort of healthy volunteers has been dosed in a phase I clinical trial of AK0406, a nove...

April 13, 2026 | News

NovogeneAIT Genomics Appointed To Advance PRECISE SG100K Proteomics Study In Singapore

NovogeneAIT Genomics announces its appointment as the designated service provider for the PRECISE-SG100K proteomics project. In this role, NovogeneAIT...

April 13, 2026 | News

Miracell Secures U.S. FDA Clearance For SMART M Cell System Advancing Regenerative Therapies

Blood- and bone marrow-based efficient growth factors extraction system demonstrates substantial equivalence and high cell viability Miracell, a...

April 13, 2026 | News

TriNetX Acquires Zetta Genomics Assets To Strengthen Multiomic Data Capabilities

TriNetX® will continue to support all existing Zetta Genomics customers utilizing the award-winning XetaBase® technology for research and patient c...

April 09, 2026 | News

Everest Medicines To Acquire Hasten Biopharmaceuticals Singapore Unit In USD 250 Million Deal

Accelerates Asia Pacific expansion by acquiring a ready-built regional commercial platform with 14 marketed chronic disease products Aggregate considera...

April 09, 2026 | News

ATLATL And Daiichi Sankyo Partner To Advance APAC Driven Biopharma Innovation

ATLATL Innovation Center (hereinafter referred to as "ATLATL"), a global innovation platform for life science research and development, announced an agreem...

April 09, 2026 | News

Stay Connected